Precipio Inc (PRPO) Stock Analysis

Precipio Inc (PRPO) is a publicly traded company in the HEALTHCARE sector. It trades at $22.48, carries a market capitalization of $40.27M. This page summarizes the public market data, fundamentals, and frequently asked questions for PRPO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

Market Sentiment

Precipio Inc currently has a Bearish sentiment score of -0.29.

About Precipio Inc

Precipio, Inc. is a leading oncology diagnostics and reagent technology company headquartered in New Haven, Connecticut, dedicated to revolutionizing cancer diagnosis and enhancing patient outcomes. The company leverages cutting-edge technologies to deliver a comprehensive suite of diagnostic products and services tailored for healthcare providers in the U.S. oncology market. With a strong commitment to precision medicine, Precipio stands at the forefront of improving treatment selection and ...

GNG Research Analysis

GNG Research scores Precipio Inc (PRPO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRPO.

Frequently Asked Questions

Does PRPO pay dividends?

Precipio Inc (PRPO) does not currently pay a regular dividend.

What is PRPO's market cap?

Precipio Inc (PRPO) has a market capitalization of $40.27M with a current stock price of $22.48.